Tagomics

Transforming disease diagnosis through comprehensive multiomic profiling

Tagomics has developed a technology and supporting processes for epigenetic-based cancer tests. The science behind the epigenome and its link to cancer is well established; however current methods to assess the epigenome are complex and expensive and can prohibit multi-sequencing approaches. The Tagomics approach is differentiated with early validation showing that is more accurate, cheaper, and faster than incumbent technologies.

  • Investment status Current
  • Invested 2024
  • Category Health & Life Sciences